XRAY
DENTSPLY SIRONA Inc.
- Healthcare
- US companies in Healthcare (47)
- NASDAQ · USD
- Mkt cap $1.9bn
$9.61
as of 29 Oct 2026, 35% below its 52-week high
Signals point to elevated dividend-cut risk, and it also screens as less well placed to keep growing its dividend.
These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.
- Trailing yield
- 1.66%Last 12 months of regular payments at today's price
- Earnings cover
- Not availableEarnings over dividends paid
- Cash cover
- 1.5×Free cash flow over dividends paid
- 5y dividend growth
- +9.9% a yearNo cut since FY2007
Compared with US companies in Healthcare (47)
- Trailing yield is higher than 32 of the 46 other US companies in Healthcare.
- 5y dividend growth (as paid) is higher than 27 of the 38 other US companies in Healthcare with a 5y growth figure.
Quality
36
LowCapacity to keep growing the dividend
Risk
75
HighSignals of dividend-cut pressure
Trim
14
LowHow extended the valuation looks
Why Risk is 75
XRAY against US companies in Healthcare (47)
Valuation against its own history
As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of XRAY’s past readings.
- Yield3.02%P84, good for this measure
- FCF payout67.1%P89, poor for this measure
- Net debt / EBITDA22.29P94, poor for this measure
- DGR 5y-4.8%P0, poor for this measure
- ROIC8.1%P100, good for this measure
Forecast your income with the XRAY dividend calculator
Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.